![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 48, 44590-44597, November 30, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,From the Institute of Microbial Technology, Sector 39A, Chandigarh 160 036, India
Received for publication, June 12, 2001, and in revised form, August 16, 2001
| |
ABSTRACT |
|---|
|
|
|---|
The B-subunit of phosphate-specific transporter
(PstB) is an ABC protein. pstB was polymerase chain
reaction-amplified from Mycobacterium tuberculosis and
overexpressed in Escherichia coli. The overexpressed
protein was found to be in inclusion bodies. The protein was
solubilized using 1.5% N-lauroylsarcosine and was purified
by gel permeation chromatography. The molecular mass of the protein was
~31 kDa. The eluted protein showed ATP-binding ability and exhibited
ATPase activity. Among different nucleotide triphosphates, ATP was
found to be the preferred substrate for M. tuberculosis
PstB-ATPase. The study of the kinetics of ATP hydrolysis yielded
Km of ~72 µM and
Vmax of ~0.12 µmol/min/mg of protein.
Divalent cation like manganese was inhibitory to the ATPase activity.
Magnesium or calcium, on the other hand, had no influence on the
functionality of the enzyme. The classical ATPase inhibitors like
sodium azide, sodium vanadate, and N-ethylmaleimide were
without any effect but an ATP analogue,
5'-p-fluorosulfonylbenzoyl adenosine, inhibited the ATPase
function of the recombinant protein with a Ki of
~0.40 mM. Furthermore, there was hardly any ATP
hydrolyzing ability of the PstB as a result of mutation of the
conserved aspartic acid residue to lysine in the Walker motif B,
confirming the recombinant protein is an ATPase. Interestingly, analysis of the recombinant PstB revealed that it is a thermostable ATPase; thus, our results highlight for the first time the
presence of such an enzyme in any mesophilic bacteria.
Importance of phosphate as an essential component of
several biomolecules, such as membrane lipids, complex carbohydrates, nucleic acids, etc., is well known. Therefore, assimilation of phosphate from the environment and its metabolism are essential events
for microorganisms for their survival. As phosphate is often a limiting
nutrient, its import in bacteria is accomplished through several
parallel transport systems (1, 2). Phosphate-specific transporter
(Pst)1 is one of them that
has been reported to be present in several bacteria like Bacillus
subtilis (3), Escherichia coli (4, 5),
Mycobacterium tuberculosis (6, 7), Salmonella
typhimurium (5), Streptococcus pneumoniae (8), etc. Pst
is a tightly regulated high affinity system grouped under ATP-binding
cassette (ABC) transporters, which includes the largest family of
paralogous proteins that are present in wide variety of cells including
those of mammals (9-11). Expression of Pst is operon-controlled, and the import function of this multisubunit transporter is known to be
operative only during phosphate limitations (see Ref. 5 and references
therein). Besides transporting phosphate, the Pst system in bacteria
has also shown to be involved in controlling a number of co-ordinately
regulated genes, grouped under the pho regulon (5).
Interestingly, among the available prokaryotic genome sequences, only
in M. tuberculosis have three putative pst
operons been identified (6, 7). Therefore, it has been thought that
many copies of the same phosphate transporter in mycobacteria might be
involved in subtle biochemical adaptations of this microorganism for
its growth and survival under highly varying (e.g.
phosphate-limiting) conditions during infectious cycle (2). Besides
phosphate transport, the role of this transporter in coping up with
adverse situations in mycobacteria has also been postulated (6,
12-14).
In most of the prokaryotes, Pst is found as a membrane-associated
complex. In E. coli it is composed of four distinct subunits encoded by pstS, pstA, pstC, and
pstB genes (4) and arranged in an operon as
pstSCAB (5, 15). PstS is the periplasmic binding protein.
The PstA and PstC are integral membrane channel proteins and are
hydrophobic in nature. PstB subunit, which is often referred as ABC
protein (16), provides energy for transport through ATP hydrolysis (5).
Available reports indicated the similar organization of the genes of
the pst operon in other prokaryotes (17, 18) as well, except
for mycobacteria (7, 19). In M. tuberculosis, the presence
of several copies of all the components of the operon except for PstB
has been reported (6, 7).
Bacterial ABC proteins have been shown to be responsible for ATP
binding as well as ATP hydrolysis, which is evident from the studies
with histidine and maltose transporters from S. typhimurium (16, 20, 21). In fact, structural data with the ATP-binding component
of the S. typhimurium histidine permease corresponded well
with the biochemical studies (22). Even the homologous component of the
Pst in E. coli has already been shown to possess ATP
hydrolyzing ability (23).
The ATP-binding subunit of the bacterial ABC transporters have also
been implicated in diverse biological functions (24-26). We have
reported previously that pstB is overexpressed as well as
amplified in a fluoroquinolone-resistant colony of Mycobacterium smegmatis, suggesting a novel role of this subunit in addition to
its involvement in the process of phosphate import (13, 14, 27).
Furthermore, among all the prokaryotic genome sequences available so
far, pstB has been found to be present throughout, giving
strong indications that this gene might be important for the
microorganisms. We therefore focused our effort to gain an insight on
the nature of the mycobacterial PstB protein.
In this article, we report that, unlike other prokaryotic ABC proteins,
the ATP hydrolyzing ability of PstB from M. tuberculosis is
rather magnesium-independent and resistant to known ATPase inhibitors.
Furthermore, our results convincingly established that the
mycobacterial PstB is a thermostable ATPase and thus highlighted the
presence of such an enzyme in any mesophilic bacteria.
Materials--
Restriction/modifying enzymes and other molecular
biological reagents were obtained from either New England Biolabs or
Promega Corp. ATP-binding protein detection kit (Roche Molecular
Biochemicals), ECL Western blotting detection kit (Amersham Pharmacia
Biotech), Expand high fidelity PCR system (Roche Molecular
Biochemicals), plasmid preparation kits (Qiagen), protein molecular
weight markers (Sigma), x-ray film (Eastman Kodak) were commercially
available. All other chemicals including urea, Triton X-100, guanidine
hydrochloride, N-lauroylsarcosine (Sarkosyl), etc. were
procured from Sigma. All oligonucleotides used in this study were
custom synthesized from PMK International. [ PCR Amplification, Construction of Recombinant Plasmids, and
Generation of Site-directed Mutant of PstB--
The forward (CS1,
5'-CATATGGCGTGTGAACGGCTC-3') and reverse (CS2,
5'-CTTTCTGAGCTCTTCAATT-3') primers for PCR amplification of
pstB (Rv0933) were designed on the basis of the published
M. tuberculosis genome sequence (7). CAT in primer CS1 does
not correspond to the genome sequence. It was introduced in CS1 to incorporate a NdeI site at the 5' end of the amplified PCR
fragment. Genomic DNA from M. tuberculosis H37Rv (obtained
as a gift from Dr. Jaya Tyagi, Department of Biotechnology, All India
Institute of Medical Sciences, New Delhi, India) was used as the
template in Expand high fidelity PCR system (Roche Molecular
Biochemicals). PCR was carried out for 30 cycles (denaturation at
94 °C for 30 s per cycle, annealing at 50 °C for 30 s
per cycle, and elongation at 68 °C for 1 min for first 10 cycles;
for the remaining 20 cycles, the elongation step was extended for an
additional 5 s in each cycle). Following treatment with Klenow,
the blunt-ended pstB was cloned at the EcoRV site
of pBluescript (SK+) and the construct was designated as pCJS1. The
nucleic acid sequence of the pstB was confirmed using an
automated sequencer (ABI, PerkinElmer Applied Biosystems).
The pstB fragment from pCJS1 was excised following
restriction digestions with NdeI and BamHI (the
enzyme site is absent in pstB but present in the vector and
located at 3' end after the stop codon) and subcloned at the
corresponding sites in pET 23a (28). Following transformation in
E. coli strain DH5
Genomic DNA from E. coli strain K12 (MTCC 1302) was also
extracted following standard procedures (29). For PCR amplification of
pstB from E. coli, the primers (CS3,
5'-GATTGCATATGAGTATG-3'; CS4, 5'-GAGACTGTCCATAACGCA-3') were designed
based on the published sequence (4) and the same strategy was adopted
for cloning (pCRC2) into expression vector.
PCR was employed to generate D188K (aspartic acid is replaced by
lysine at amino acid residue 188) mutant in the Walker B motif (30) of
the M. tuberculosis PstB. Two forward (CS1 and CS9) and two
reverse primers (CS19 and CS21) were used for this purpose. Primers
(CS9, 5'-GTTGCTGCTCAAGGAGCCCACC-3'; CS19,
5'-ACTTCAATTTCCGCGCTTGGC-3'; and CS21,
5'-GGTGGGCTCCTTGAGCAGCAAC-3') were designed
based on M. tuberculosis pstB sequences and base mismatches
(underlined) were incorporated to obtain desired mutations. To generate
the mutant, two sets of primary and one set of secondary PCR reactions were carried out (31) using the gel-purified wild type pstB (831 base pairs) as template. Primary reactions were carried out with
primers CS1/CS21 and CS9/CS19, whereas for secondary PCR reaction CS1
and CS19 were used. Thus, D188K mutation was contained within the
amplified fragment of the PstB. Secondary PCR product was
restriction-digested with AatII, which yielded a 655-base pair fragment containing the desired mutation, and finally substituted for the corresponding wild type fragment cloned in expression vector.
Mutations were confirmed by sequencing.
Expression of Recombinant Protein--
The pCJS2 was transformed
into E. coli strain BL21(DE3) and selected on LB-ampicillin
plates (100 µg/ml). Overnight cultures (~15 h at 37 °C) of
several colonies were reinoculated and grown until
A600 reached ~0.45. Cultures were then induced
with 0.4 mM
isopropyl- Purification of Recombinant Proteins--
Pellet fractions
obtained following centrifugation of IPTG-induced sonicated cells
(transformed either with pCJS2 or pCRC2) were washed in wash buffer
(lysis buffer supplemented with 4 M urea and 5% Triton
X-100) following the procedure described elsewhere (32). The washed
pellets (inclusion bodies containing expressed protein) were suspended
in TEN buffer (10 mM Tris, 1 mM EDTA, and 150 mM NaCl, pH 7.5) containing 1.5% Sarkosyl, and were
subjected to ultracentrifugation (107,000 × g for
1 h at 4 °C in an ultracentrifuge, Beckman). The supernatant
fractions collected in this way contained solubilized protein and were
subjected to gel permeation chromatography in a fast protein liquid
chromatography unit (Amersham Pharmacia Biotech) using Superdex 200 column. Protein was eluted with TEN buffer containing 0.15% Sarkosyl.
Antibodies--
The inclusion body containing PstB protein from
M. tuberculosis was solubilized using buffer (50 mM Tris, 5 mM EDTA, and 5 mM
dithiothreitol, pH 7.5) containing guanidine hydrochloride (8 M) following standard procedures (32). The denatured
protein obtained in this way (purity ~85%, as evidenced by SDS-PAGE)
was precipitated by removing guanidine hydrochloride through dialysis (buffer: 50 mM Tris, 5 mM EDTA, 5 mM dithiothreitol, and 1 M NaCl, pH 7.5) and
was used to raise polyclonal antibodies in rabbit. Briefly, purified
protein (~800 µg) emulsified in complete Freund's adjuvant was
injected subcutaneously at multiple sites. Boosters were emulsified in
incomplete Freund's adjuvant and were given at the same dose at
intervals of 21 days. After the third booster dose, blood was collected
and sera prepared was decomplimented at 56 °C for 30 min. The
antibody titer was determined by indirect enzyme-linked immunosorbent
assay using horseradish peroxidase-conjugated anti-rabbit IgG as
secondary antibody and 2,2'-azinobis(3-ethylbenzthiazolinesulfonic acid) as substrate. The antisera showed cross-reactivity to PstB from
E. coli. Similarly, antibody raised against E. coli PstB (obtained as a gift from Dr. A. Torriani, Massachusetts
Institute of Technology, Cambridge, MA) recognized mycobacterial
PstB.
Detection of ATP-binding Ability--
ATP-binding ability of the
recombinant PstB was monitored by labeling the protein with a
nonhydrolyzable ATP analogue, 5'-p-fluorosulfonylbenzoyl adenosine (FSBA). For the labeling reaction, the recombinant PstB protein (dissolved in borate buffer, pH 7.4, supplemented with 0.15%
Sarkosyl) was incubated (30 min at 30 °C) with 1-3 mM
FSBA. The samples were run on SDS-PAGE, followed by detection through Western blotting using anti-FSBA antibody.
ATPase Assay--
The ATPase activity of the protein was
quantitated by a colorimetric assay performed in microtiter plates
following the method described by Henkel et al. (33).
Briefly, PstB protein (0.5 to 1 µg) was diluted with TEN buffer to a
final volume of 25 µl. The reaction was initiated by adding equal
volume of substrate solution (ATP final concentration = 1 mM; unless mentioned otherwise), followed by incubation at
37 °C for 5 min (final Sarkosyl concentration = 0.06%). The
enzymatic reaction was terminated by addition of an acidic solution
(200 µl) of malachite green, ammonium molybdate, and polyvinyl
alcohol (33). The activity was measured as the amount of inorganic
phosphate (Pi) liberated that forms a phosphomolybdate malachite complex detected at 650 nm in an enzyme-linked immunosorbent assay plate reader. The values obtained were corrected by subtracting the blank readings obtained for nonenzymatic release of Pi
because of hydrolysis of ATP and Pi contamination in the
absence of enzyme as well as substrate. A standard curve with sodium
phosphate monobasic was run concurrently with each experiment, and thus
nanomoles of Pi released were calculated. ATPase activity
is expressed as nanomoles of Pi liberated/min/mg of
protein, and the data presented in the form of mean ± S.D.
EDTA was omitted from the Sarkosyl-supplemented TEN buffer in carrying
out studies with divalent cations. The effect of different divalent
cations (Ca2+, Mg2+, and Mn2+) on
the ATPase activity was monitored by adding them in the presence or
absence of 5 mM EDTA prior to incubation with substrate
solution. Different inhibitors used in this study were sodium azide,
N-ethylmaleimide, and sodium orthovanadate. All inhibitors
were dissolved in assay buffer, except for N-ethylmaleimide,
which was in ethanol. To elucidate the effect of
N-ethylmaleimide, final concentration of ethanol during the
assay was adjusted to 0.6% and accordingly proper blank was
maintained. The influence of inhibitors was determined by incubating
(15 min or 3 h at room temperature) them with the protein prior to
the addition of substrate solution.
Raleigh's Scattering--
Effect of temperature (80 °C) for
different time periods (0-60 min) on aggregation pattern of PstB
proteins from M. tuberculosis and E. coli in
solution (protein concentration of ~100 µg/ml in TEN buffer
containing 0.06% Sarkosyl) was examined by studying Raileigh's
scattering at 600 nm ( Southern Hybridization--
To confirm cloning of PCR products
in vectors, Southern hybridization was carried out following standard
protocols (29) using [ Western Blotting--
Western blotting was employed to examine
the expression of PstB protein or to detect FSBA-bound protein. Protein
was estimated following Bradford's method (34). Purified proteins or
cell extracts (800 ng to 3 µg protein/slot) were resolved in SDS-PAGE and transferred at 100 V for 45 min to nitrocellulose membrane (0.45 µm) in a mini-transblot apparatus (Bio-Rad) using Tris-glycine buffer
(48 mM Tris, 39 mM glycine, 0.037% SDS, and
20% methanol, pH ~8.3). Blots were probed with primary (anti-PstB or
anti-FSBA) and secondary (horseradish peroxidase-conjugated anti-rabbit
IgG) antibodies and processed with ECL detection system as described elsewhere (31). Stripping of the blots, if necessary, was done following the manufacturer's recommended protocol (Amersham Pharmacia Biotech).
Overproduction of the Protein--
The pstB gene from
M. tuberculosis strain H37Rv was amplified by PCR.
pstB-specific primers (CS1 and CS2) were designed based on
the published M. tuberculosis genome sequence (7). PCR was carried out at annealing temperature of 50 °C with primers and genomic DNA utilizing a mixture of Taq and Pwo
DNA polymerase, which resulted in the amplification of expected
~831-base pair fragment. Only those reactions, which contained
template DNA, primers, and enzymes, showed the amplification (data not
shown). The PCR-amplified fragment was cloned in pBluescript (SK+) and was sequenced. A base pair change was observed at codon 235. However, it did not result in alteration of any amino acid because codon 235, AAG (coding for phenylalanine), was altered to AAA.
PstB was overexpressed following subcloning in pET23a (see
"Experimental Procedures"). Several colonies showed the
overexpression of the protein, as evidenced by an expected band of
~31 kDa in SDS-PAGE following staining with Coomassie Brilliant Blue
in cultures transformed with pCJS2 and induced with IPTG. One of these
colonies was selected for further processing (Fig.
1). However, the expressed protein was
observed in the pellet fraction (inclusion bodies) in SDS-PAGE analysis
(Fig. 1, lane 4). Cultures grown at even lower temperatures
did not yield any soluble protein. Such an event is not restricted to
PstB from M. tuberculosis only because homologous protein
from E. coli when expressed following transformation of
pCRC2 was also found to be in inclusion bodies (data not shown). PstB
aggregates were partially solubilized with 1.5% Sarkosyl (Fig. 1,
compare lanes 6 and 7) and were purified by gel
permeation chromatography. Column elutes formed a single peak within
the separation range of Superdex 200, SDS-PAGE analysis of which is also shown in Fig. 1 (lanes 8 and 9). The
molecular weight of the eluted protein obtained through gel permeation
chromatography was found to be 69.3 ± 3.25 (mean ± S.D.,
n = 7), whereas the same samples subjected to SDS-PAGE
revealed a molecular mass of 30.5 ± 1 kDa (mean ± S.D.,
n = 5). Western blot with the anti-PstB antibody
recognized the purified protein (Fig. 2).
Thus our data argue that the active form of the PstB from M. tuberculosis is possibly a dimer. This is not unusual because the
nucleotide-binding subunits of bacterial ABC transporters are known to
be active as dimer (21, 23, 35).
PstB Is an ATP-binding Protein--
Nucleotide-binding subunits of
different bacterial ABC transporters including PstB from E. coli have been shown to bind ATP (23, 36). To gain insight on this
aspect, we utilized the binding ability of FSBA at the nucleotide
binding sites of such proteins through covalent modification (37).
Following labeling of protein (purified in borate buffer) with FSBA (1 or 3 mM) or treating with Me2SO (solvent
control), samples were subjected to SDS-PAGE and immunoblotting using
anti-FSBA antibody. As shown in Fig. 2A, anti-FSBA antibody
recognized only those samples that were incubated with FSBA
(lanes 2 and 3). On the other hand, the same
blot, following stripping, when probed with anti-PstB antibody, recognized all the samples (Fig. 2B). This result reflected
the binding ability of the purified protein specifically to FSBA and thus argues that the PstB of M. tuberculosis is also an
ATP-binding protein.
PstB of M. tuberculosis Is an ATPase--
The ATP-binding subunit
of bacterial ABC transporters has been reported to exhibit the ATPase
activity (20, 21, 36). We therefore investigated the ATPase activity of
the recombinant PstB of M. tuberculosis. The protein was
able to hydrolyze ATP at a pH range between 5 and 10 (data not shown),
and, unless mentioned otherwise, enzymatic characterization was carried
out at pH 7.5. The kinetics of ATP hydrolysis revealed a
Km value of ~72 µM for mycobacterial
protein as opposed to ~24 µM in E. coli PstB
(Table I). The Km
value is quite comparable with ATPase activity exhibited by S. typhimurium MalK (Tables I and II), whereas velocity of the
reaction as reflected in the Vmax value was
lower (see Table I and Ref. 20). PstB was also found to hydrolyze GTP
as well as CTP and thus exhibited broad range of substrate specificity.
However, compared with ATP, the affinity of the PstB for CTP or GTP as
substrate was significantly lower (Table
II, compare the Km
values).
Divalent cations are known to influence the ATP hydrolyzing ability of
the nucleotide-binding subunit of bacterial ABC transporters (20, 21).
As shown in Fig. 3A, ATPase
activity of PstB was inhibited by Mn2+. Such an inhibition
of the enzyme activity was Mn2+-specific because the effect
was abolished when incubation was carried out in the presence of metal
ion chelator, EDTA. On the other hand, ATP hydrolysis of PstB was
unaffected when incubated either with Mg2+ or
Ca2+ in the presence or absence of EDTA (Fig. 3,
B and C). In contrast, MalK-ATPase activity in
S. typhimurium was found to be strongly Mg2+-dependent (20).
ATPases are often grouped into F-, P-, and V-types based on the effect
of their specific inhibitors (38). The influence of these inhibitors on
the ATPase activity associated with M. tuberculosis PstB was
examined following 15 min or 3 h of preincubation at room
temperature. The results of short term (15 min) incubation of PstB with
different inhibitors are depicted in Fig.
4A. Sodium azide, an inhibitor
of mitochondrial and bacterial proton (F0F1) ATPase, up to a concentration of 30 mM did not affect the
ATP hydrolyzing ability of PstB. Similarly, sodium orthovanadate, which
is known to be a P-type ATPase inhibitor, did not have any effect (up
to 10 mM) on the enzyme activity. The enzymatic activity of
PstB was also resistant to inhibition up to a concentration of 30 mM by N-ethylmaleimide, a V-type ATPase
inhibitor. To know whether these results are experimental artifacts,
ATPase activity of PstB was determined following treatment with a
denaturant like guanidine hydrochloride (8 M) and taking
boiled samples (5 min at 100 °C). As expected, treatment with
guanidine hydrochloride caused a significant reduction in the
PstB-ATPase activity. Surprisingly, samples following boiling did not
show any significant reduction in enzyme activity (Fig. 4A,
inset). Furthermore, to rule out the possibility that short
term incubation (15 min) with these inhibitors was not a factor in
affecting the enzyme activity, PstB-ATPase activity was monitored
following treatment with them at 10 mM concentrations for a
3-h period. As shown in Fig. 4B, none of these inhibitors
could affect the ATPase activity.
To confirm ATPase activity of PstB, enzymatic hydrolysis of ATP was
monitored following incubation with nonhydrolyzable substrate analogue,
FSBA. This study was carried out with protein extracted and purified in
borate buffer, pH 7.4, containing 0.15% Sarkosyl to prevent
nonspecific reaction of FSBA with free amines in the buffer. Samples
were incubated (30 min at 30 °C) with FSBA (0-4 mM),
and then ATPase activity was determined following addition of different
concentrations (250-750 µM) of substrate solution. FSBA
preincubation significantly inhibited the PstB-ATPase activity (Fig.
5A). The Ki
value for FSBA was 0.4 ± 0.05 mM (n = 3). FSBA inhibited the enzyme activity by competing with ATP for the
substrate binding site, which is evident from the shift in apparent
Km value of the enzyme (70 ± 5, 99 ± 11.5, and 155 ± 26 µM in presence of 0, 1.5, and 3 mM FSBA, respectively), but Vmax
remained unaltered (Fig. 5B).
To confirm further that the recombinant PstB is an ATPase, we studied a
mutant (D188K) that is known to affect the ATP hydrolyzing ability of
the bacterial ABC proteins (22, 39, 40). Unlike wild type PstB,
incubation with increasing concentrations of ATP (62.5-2000
µM), the mutant protein hardly displayed any ATPase activity (Fig. 6A). Similarly,
use of increasing concentrations of mutant protein (0.5-2 µg) showed
negligible enzyme activity. In fact, ATPase activity when compared
between wild type and D188K by plotting as a function of amount of
protein used in the assay exhibited slopes that are very distinct from
each other (Fig. 6B).
PstB-ATPase Is Thermostable--
Characterization of thermostable
bacterial ATPases have already been reported (41, 42); however, none of
them was identified from any mesophilic bacteria. Because boiling of
protein did not affect the enzymatic activity of the PstB-ATPase of
M. tuberculosis (Fig. 4A), we therefore
concentrated on determining its thermostability profile. Aggregation
pattern of the recombinant PstB protein in response to temperature was
monitored through Raleigh's scattering. In addition to the buffer (TEN
buffer containing 0.06% Sarkosyl, the condition used for assaying
ATPase activity) as a control for this study, the well characterized
E. coli PstB expressed and purified in a similar manner (see
"Experimental Procedures") was also examined. In a preliminary
experiment, aggregation patterns of these proteins were examined after
incubating for 15 min at different temperatures (25-80 °C).
Interestingly, the E. coli PstB precipitated following
incubation at 80 °C, whereas mycobacterial protein hardly showed any
aggregation (data not shown). We further monitored the aggregation
profile of these two proteins by incubating at 80 °C for different
time periods (0-60 min). As depicted in Fig.
7A, the aggregation of
E. coli protein increased with the time of incubation.
Incubation of these proteins for 1 h indicated a low level of
aggregation with PstB from M. tuberculosis (30.2 ± 7.23 arbitrary units; buffer only: 7.3 ± 1.89 arbitrary units) compared with that of the E. coli (188 ± 7.4 arbitrary
units). Furthermore, when the heated samples (after centrifugation to remove precipitated proteins) were subjected to SDS-PAGE followed by
Coomassie Brilliant Blue staining, unlike M. tuberculosis
protein a decrease in signal intensity of the bands could be visualized clearly with the E. coli samples (Fig. 7B). The
identity of these proteins was confirmed by Western blotting using
anti-PstB antibody (data not shown). As reflected in the ATPase assays
of these samples, thermal denaturation of E. coli protein
was evident within 5 min of its incubation at 80 °C (Fig.
8A). The maximum loss of
enzyme activity for E. coli PstB was ~60% of initial
value, which was noticed between 30 and 60 min. of heat incubation;
however, the remaining ~40% was found to be heat-resistant.
Interestingly, mycobacterial PstB even after heat treatment (80 °C)
for 1 h retained ~89% (loss = ~11%) of its initial
ATPase activity (Fig. 8A). We further compared the enzymatic
activities of both the proteins by incubating with the substrate (1 mM ATP for 5 min) at different temperatures (24-80 °C).
The PstB from E. coli showed substantial loss in the ATPase
activity at temperatures above 37 °C. On the other hand, M. tuberculosis enzyme was found to be heat-resistant (Fig.
8B). Thus our results argue that the ATP-binding subunit of
the phosphate-specific transporter from M. tuberculosis is a
thermostable ATPase.
Phosphate is an essential but often limiting nutrient, especially
for pathogenic bacteria like M. tuberculosis, which faces rapidly changing environment within the host during the infectious cycle. To create a congenial environment for their survival, several phosphate importers are present in mycobacteria (2). Pst system is one
of such importers belonging to the superfamily of ABC permeases and is
known to be operative in bacteria in phosphate-limiting conditions (5).
Pst is a multisubunit transporter, and its expression is
operon-controlled. PstB of M. tuberculosis is the nucleotide-binding subunit of the phosphate-specific transporter (6).
Like other ABC proteins, being the energy transducing unit, PstB in
M. tuberculosis has a vital role in the ATP-consuming import
of phosphate. Apart from this, Pst system in M. tuberculosis gains additional importance because several copies of all the components of the operon is present in the genome but there is single
copy of pstB gene (6, 7). Furthermore, our earlier reports
indicated that pstB is overexpressed as well as amplified in
a fluoroquinolone-resistant colony of M. smegmatis, where
drug efflux plays a pivotal role in conferring resistance (13, 14, 27).
These consequences, together with the fact that ABC proteins are
involved in diverse biological processes (24-26), led us to characterize the PstB subunit from M. tuberculosis.
Like other ABC proteins (21, 23, 36), overexpression of PstB in
E. coli resulted in its accumulation as aggregates, and it
was found to be in pellet fractions (inclusion bodies) following
centrifugation of sonicated cultures (Fig. 1). The formation of such
aggregates was not unusual and could be the result of incorrect folding
of the expressed protein (43, 44). The renaturation of solubilized
protein in urea or guanidine hydrochloride proved to be a difficult
task because it yielded completely denatured protein, which could not
be refolded following conventional methods (32). Finally, the protein
was obtained mostly in soluble form using a mild ionic detergent
N-lauroylsarcosine (Fig. 1). Furthermore, the binding of the
ATP analogue, FSBA, ensured the correct folding of this recombinant
protein (Fig. 2). Analyses of the size of the native (obtained through
gel filtration chromatography) and denatured (as in SDS-PAGE gels as
well as in Western blots) proteins revealed that the PstB presumably
existed as a dimer. ABC proteins in bacteria have been shown previously
to be active as dimer (21, 23, 36, 45). Therefore, this did not seem to
be a unique feature for mycobacterial protein. Additionally, the
monomeric form (~31 kDa) did not exhibit any shift in the molecular
mass when samples were subjected to SDS-PAGE in nonreducing conditions, suggesting no interaction between intermolecular thiols in forming the
putative dimer of the protein (data not shown).
ABC proteins have also been shown to have ATP hydrolyzing ability,
which is very important for the functionality of the transporter (40).
Our results indicated that ATPase activity could be inhibited if
incubated with FSBA (Fig. 5A). This suggests a possible
competition of the nonhydrolyzing ATP analogue with ATP for substrate
binding site, which is evidenced by unaltered
Vmax but increase in apparent Km during the activity assay in presence of
inhibitor (Fig. 5B). Moreover, mutation in the conserved
aspartic acid residue in the Walker motif B, which is known to affect
ATPase activity in other ABC proteins (22, 39, 40), exhibited hardly
any ATP hydrolyzing ability of the recombinant PstB (Fig. 6).
Thus, these two lines of evidence argue in favor of M. tuberculosis PstB being an ATPase.
Although the ATP hydrolyzing ability of mycobacterial PstB exhibited
many properties characteristic to typical ABC proteins (Table I),
subtle differences made it distinct from others, like MalK or HisP from
S. typhimurium. For example, among different nucleotides,
ATP has been found to be a preferred substrate for the recombinant PstB
(Table II). Similarly, divalent cations (Mg2+ and
Ca2+) that have been reported to be stimulatory for the
enzymatic activity (20, 21) had no effect on mycobacterial PstB-ATPase (Fig. 3). Like membrane-bound thermostable ATPase from Sulfolobus acidocaldarus (46), the enzymatic activity of mycobacterial PstB
was found to be resistant to known inhibitors such as sodium orthovanadate and sodium azide. Although such an observation has also
been found to be true for HisP or MalK (20, 21),
N-ethylmaleimide, which had a strong inhibitory effect on
their activity, was unable to affect the mycobacterial enzyme (Fig. 4).
The sensitivity of these proteins to N-ethylmaleimide has
often been correlated to the presence of a cysteine residue at or near
the highly conserved Walker motif A (20). Interestingly, no such
cysteine residue is present in M. tuberculosis PstB.
Several thermostable ATPases have been characterized (41, 42, 46);
however, they all are present in thermophilic bacteria. Therefore, what
makes our finding significant is not only the fact that the recombinant
PstB being an ATPase is thermophilic but the presence of such a
thermostable enzyme in a mesophilic bacteria like M. tuberculosis. Studies regarding thermal aggregation profile of the
recombinant protein through Raleigh's scattering (Fig. 7A)
and subsequent monitoring of enzymatic activities indeed showed that
PstB-ATPase from M. tuberculosis is thermostable compared with its E. coli counterpart (Fig. 8A).
Furthermore, activity assays with both the ATPases confirmed that
M. tuberculosis PstB was more efficient in exhibiting its
functionality at temperatures above 37 °C (Fig. 8B).
However, 38-49% of E. coli PstB protein was found to be
heat-resistant (Fig. 8). The fact that, during the process of thermal
inactivation of an enzyme, a significant amount of unfolding
intermediates could be reactivated by addition of the substrate (47,
48) might explain why such an event is not unusual.
Like other thermostable proteins, comparison of nucleotide-derived
amino acid sequences of M. tuberculosis PstB revealed that there is an increase in Finally, the detailed study on the thermostability of other ABC
proteins is not available as yet; therefore, such a property brings
them in sharp focus and indicates that they might be playing a more
pivotal role in bacteria than a cursory glance reveals.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]dCTP
was supplied by Jonaki Laboratories, BRIT, Hyderabad, India.
, plasmid DNA was extracted and the
construct (pCJS2) was verified by restriction digestions.
-D-thiogalactopyranoside (IPTG). Cells were
harvested after 2 h, lysates were prepared, and expression was
checked by running 12% SDS-PAGE, followed by Coomassie Brilliant Blue
staining. To know the solubility of the expressed protein, cells after
induction were suspended in lysis buffer (100 mM Tris, pH
7.5, containing 5 mM EDTA, 5 mM dithiothreitol,
and 5 mM phenylmethylsulfonyl fluoride), treated (20 min at
24 °C) with lysozyme (200 µg/ml), and sonicated, and different
fractions (supernatant and pellet after centrifugation at 22,000 × g for 30 min at 4 °C) were subjected to SDS-PAGE
followed by Coomassie Brilliant Blue staining.
excitation =
emission) in a fluorometer (PerkinElmer Life Sciences).
-32P]dCTP-labeled probes.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (79K):
[in a new window]
Fig. 1.
Summary of purification of M. tuberculosis PstB expressed in E. coli. Overnight
cultures BL21(DE3) cells transformed with pCJS2 were reinoculated and
grown until A600 was ~0.45. Cultures were then
induced with 0.4 mM IPTG. Cells were harvested after 2 h, and lysates were prepared and processed for purification as
mentioned under "Experimental Procedures." Protein samples at
various stages of purification were subjected to 12.5% SDS-PAGE,
followed by Coomassie Brilliant Blue staining. Lane 1, crude
extract of cells harboring plasmid pCJS-2 without IPTG induction;
lane 2, crude extract of cells harboring plasmid pCJS-2
induced with IPTG; lane 3, low speed supernatant fraction;
lane 4, pellet fraction obtained after low speed
centrifugation; Lane 5, insoluble fraction of protein
(inclusion body); lane 6, insoluble fraction of protein in
the pellet following treatment with Sarkosyl; lane 7,
soluble protein obtained after treatment with Sarkosyl; lanes
8 and 9, purified PstB obtained after gel permeation
chromatography. Position of PstB is indicated by an arrow.
Numbers denote the position of molecular size
standards.

View larger version (86K):
[in a new window]
Fig. 2.
ATP-binding ability of mycobacterial
PstB. PstB following incubation with different concentrations of
FSBA were subjected to SDS-PAGE and immunoblotting using anti-FSBA
(aFSBA) or anti-PstB (aPstB) antibodies.
Lane 1, PstB with no FSBA; lane 2, PstB with 1 mM FSBA; lane 3, PstB with 3 mM
FSBA.
Kinetics of ATPase activity exhibited by PstB
Affinity of mycobacterial PstB-ATPase for different substrates

View larger version (13K):
[in a new window]
Fig. 3.
Effect of divalent cations on PstB-ATPase
activity. The ATPase activity of the recombinant PstB was
determined using 1 mM ATP with indicated concentrations of
manganese (A), magnesium (B), and calcium
(C) in presence or absence of EDTA. The data were expressed
as percentage of control in each case, and reproducibility was checked
in four to seven independent experiments.

View larger version (17K):
[in a new window]
Fig. 4.
Effect of inhibitors on ATPase activity
exhibited by PstB. PstB was preincubated with different ATPase
inhibitors for 15 min (A) and 3 h (B) at
room temperature. 10 mM amounts of each inhibitor were used
for the experiment where preincubation was carried out for 3 h.
ATP hydrolysis was measured under standard conditions as described
under "Experimental procedures." The reproducibility was checked in
four independent experiments. Inset, effect of denaturing
agents or boiling of the enzyme on the PstB-ATPase activity.
NONE, preincubation without any inhibitor; AZ,
sodium azide; NEM, N-ethylmaleimide;
VAN, sodium orthovanadate; BOIL, heated at
100 °C for 5 min; GUA, 8 M guanidine
hydrochloride.

View larger version (17K):
[in a new window]
Fig. 5.
Inhibition of mycobacterial PstB-ATPase
activity by FSBA. A, PstB was incubated with indicated
concentrations of FSBA at 30 °C for 30 min. ATP hydrolysis was then
initiated with addition of indicated concentrations of ATP and
monitored as mentioned under "Experimental Procedures."
Points in the graph are interpolated with the data obtained
using 250 µM ATP (final concentration). Results are
means ± S.D. from three independent experiments. B,
Lineweaver-Burk plot of ATP affinity in the presence of indicated
concentrations of FSBA. The figure shows a representative experiment.
The reproducibility was checked in three independent experiments.

View larger version (15K):
[in a new window]
Fig. 6.
D188K mutant hardly shows any ATPase
activity. A, ATP hydrolyzing ability of the wild type
and the mutant was determined in presence of varied concentrations of
ATP following standard conditions as mentioned under "Experimental
Procedures." The reproducibility was checked in four independent
experiments. B, ATP hydrolyzing ability of the D188K mutant
as a function of amount of protein used in the assay. ATPase activity
for both wild type and mutant was monitored with increasing
concentrations of protein in the presence of 1 mM ATP. Data
represent means ± S.D. from three independent experiments.

View larger version (27K):
[in a new window]
Fig. 7.
Aggregation profile of PstB proteins in
response to temperature. A, purified PstB proteins from
E. coli and M. tuberculosis (in TEN buffer
containing 0.06% Sarkosyl at a concentration of ~100 µg/ml) were
incubated at 80 °C for indicated time periods, and subsequently
Raleigh's scattering was monitored at 600 nm in a fluorometer. Results
were expressed in arbitrary units (mean ± S.D.), and
reproducibility was checked in three independent experiments.
B, samples following incubation at 80 °C for 0 (lane 1), 5 (lane 2), 10 (lane 3), 30 (lane 4), and 60 (lane 5) min were centrifuged.
Supernatant fractions were subjected to 12% SDS-PAGE and visualized
after Coomassie Brilliant Blue staining.

View larger version (25K):
[in a new window]
Fig. 8.
Effect of high temperature incubation on
ATPase activity of PstB. Purified PstB proteins from E. coli and M. tuberculosis were incubated at 80 °C for
indicated time periods in microcentrifuge tubes (1 µg of
protein/reaction). Following addition of 1 mM ATP, samples
were incubated for another 5 min at 37 °C. The reaction was stopped
by addition of an acidic solution of malachite green, ammonium
molybdate, and polyvinyl alcohol. Precipitates (obtained during
incubation at 80 °C) were pelleted by centrifugation, supernatant
fractions of each samples were transferred to microtiter plates, and
amount of inorganic phosphate (Pi) liberated was monitored
following standard conditions as mentioned under "Experimental
Procedures." Reproducibility was checked in three independent
experiments. B, purified PstB proteins from E. coli and M. tuberculosis following addition of 1 mM ATP were incubated for 5 min at indicated temperatures
in microcentrifuge tubes (1 µg of protein/reaction). ATPase activity
of each sample was determined as described in A and
calculated as percentage of the activity obtained during incubation at
37 °C. Data represent means ± S.D. from three independent
experiments.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-branched (valine, ~8%) as well as
charged (aspartic acid, arginine, glutamic acid, and lysine; total
~23%) residues, which presumably confers rigidity and stability of
the protein (49, 50). Furthermore, PstB has decreased content of polar
uncharged amino acids, such as asparagine (3.2%) or glutamine (3.2%),
which is known to minimize deamidation and backbone cleavages of a
protein (50). However, many other factors, such as improved hydrogen
bonding, better hydrophobic packing, enhanced secondary structure
propensity, helix dipole stabilization, improved electrostatic interactions, etc., might have significant contribution in the process.
Insight into these properties as well as their specific contribution
toward thermophilic nature of PstB will only be unraveled once the
crystal structure is solved and complete analysis can be carried out.
| |
ACKNOWLEDGEMENTS |
|---|
We are thankful to Dr. A. Ghosh (Director, Institute of Microbial Technology, Chandigarh, India) for providing us with excellent laboratory facilities. We are grateful to Dr. T. Chakrabarti for critical reading of the manuscript. We acknowledge the helpful suggestions of Drs. A. Mondal and S. Mande during this investigation. We thank J. Prasad for providing us with excellent technical assistance during the course of this investigation and acknowledge the secretarial help provided by S. Gupta.
| |
FOOTNOTES |
|---|
* This work was supported in part by a research grant from the Department of Biotechnology, New Delhi, India.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Recipient of a senior research fellowship from the Council of
Scientific and Industrial Research, New Delhi, India.
§ To whom correspondence should be addressed. Tel.: 91-172-695215 (ext. 452); Fax: 91-172-690585; E-mail: pradip@imtech.res.in.
Published, JBC Papers in Press, September 20, 2001, DOI 10.1074/jbc.M105401200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
Pst, phosphate-specific transporter;
ABC, ATP-binding cassette;
ATPase, adenosine triphosphatase;
FSBA, 5'-p-fluorosulfonylbenzoyl
adenosine;
IgG, immunoglobulin G;
IPTG, isopropyl-
-D-thiogalactopyranoside;
PAGE, polyacrylamide
gel electrophoresis;
PCR, polymerase chain reaction;
Pi, inorganic phosphate;
PstB, B subunit of phosphate-specific
transporter.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Silver, S., and Walderhaug, M. (1992) Microbiol. Rev. 56, 195-228 |
| 2. | Braibant, M., Gilot, P., and Content, J. (2000) FEMS Microbiol. Rev. 24, 449-467 |
| 3. | Qi, Y., Kobayashi, Y., and Hulett, F. (1997) J. Bacteriol. 179, 2534-2539 |
| 4. | Surin, B. P., Rosenberg, H., and Cox, G. B. (1985) J. Bacteriol. 161, 189-198 |
| 5. | Wanner, B. L. (1996) in E. coli and Salmonella: Cellular and Molecular Biology (Neidhard, F. C. , Curtiss, R., III , Ingraham, J. L. , Lin, E. C. C. , Low, R. B. , Magasanik, B. , Reznikoff, W. S. , Riley, M. , Schaechter, M. , and Umbarger, H. E., eds), 2nd Ed., Vol. I , pp. 1356-1381, ASM Press, Washington, D. C. |
| 6. | Braibant, M., Lefevre, P., Dewit, L., Oomes, J., Peirs, P., Hugyen, K., Wattiez, R., and Content, J. (1996) FEBS Lett. 394, 206-212 |
| 7. | Cole, S. T., et al.. (1998) Nature 395, 537-544 |
| 8. | Novak, R., Cauwels, A., Charpentier, E., and Tuomanen, E. (1999) J. Bacteriol. 181, 1126-1133 |
| 9. | Higgins, C. F. (1992) Annu. Rev. Cell Biol. 8, 67-113 |
| 10. | Doige, C. A., and Ames, G. F. (1993) Annu. Rev. Microbiol. 47, 291-319 |
| 11. | Gottesman, M., and Pastan, I. (1993) Annu. Rev. Biochem. 62, 385-427 |
| 12. | Lefevre, P., Braibant, M., Dewit, L., Kalai, M., Roeper, D., Grotzinger, J., Delville, J., Peirs, P., Oomes, J., Hugyen, K., and Content, J. (1997) J. Bacteriol. 179, 2900-2906 |
| 13. | Banerjee, S. K., Misra, P., Bhatt, K., and Chakraborti, P. K. (2000) Mol. Gen. Genet. 262, 949-956 |
| 14. | Bhatt, K., Banerjee, S. K., and Chakraborti, P. K. (2000) Eur. J. Biochem. 267, 4028-4032 |
| 15. | Higgins, C. F., Hiles, I. D., Salmond, G. P. C., Gill, D. R., Downie, J. A., Evans, I. J., Holland, I. B., Gray, L., Buckel, S. D., Bell, A. W., and Hermodson, M. A. (1986) Nature 323, 448-450 |
| 16. | Hunke, S., and Schneider, E. (1999) FEBS Lett. 448, 131-134 |
| 17. | Linton, K. J., and Higgins, C. F. (1998) Mol. Microbiol. 28, 5-13 |
| 18. | Quentin, Y., Fichant, G., and Denizot, F. (1999) J. Mol. Biol. 287, 467-484 |
| 19. | Cole, S. T., et al.. (2001) Nature 409, 1007-1011 |
| 20. | Morbach, S., Tebbe, S., and Schneider, E. (1993) J. Biol. Chem. 268, 18617-18621 |
| 21. | Nikaido, K., Liu, P., and Ames, G. F. (1997) J. Biol. Chem. 272, 27745-27752 |
| 22. | Hung, Li., Wang, I., Nikaido, K., and Liu, P. (1998) Nature 396, 703-707 |
| 23. | Chan, F. Y., and Torriani, A. (1996) J. Bacteriol. 178, 3974-3977 |
| 24. | Hiles, I. D., Gallagher, M. P., Jamieson, D. J., and Higgins, C. F. (1987) J. Mol. Biol. 195, 125-142 |
| 25. | Dean, D. A., Reizer, J., Nikaido, H., and Saier, M. H. Jr. (1990) J. Biol. Chem. 265, 21005-21010 |
| 26. | Panagiotidis, C. H., Reyes, M., Sievertsen, A., Boos, W., and Shuman, H. A. (1993) J. Biol. Chem. 268, 23685-23696 |
| 27. | Banerjee, S. K., Misra, P., Bhatt, K., Mande, S. C., and Chakraborti, P. K. (1998) FEBS Lett. 25, 151-156 |
| 28. | Studier, O. F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. (1990) Methods Enzymol. 185, 60-89 |
| 29. | Sambrook, J., Fritsch, E. F., and Manitis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 30. | Walker, J., Saraste, M., Runswick, M., and Gray, N. (1982) EMBO J. 1, 945-951 |
| 31. | Rana, S., Bisht, D., and Chakraborti, P. K. (1999) J. Mol. Biol. 286, 669-681 |
| 32. | Coligan, J. E., Dunn, B. M., Ploegh, H., Speicher, D. W., and Wingfield, P. T. (1995) Current Protocols in Protein Science , John Wiley & Sons, New York |
| 33. | Henkel, R., Vandeberg, J., and Walsh, A. (1988) Anal. Biochem. 169, 312-318 |
| 34. | Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 |
| 35. | Webb, D., Rosenverg, H., and Cox, G. (1992) J. Biol. Chem. 267, 24661-24668 |
| 36. | Walter, C., Bentrup, K., and Schneider, E. (1992) J. Biol. Chem. 267, 8863-8869 |
| 37. | Anostario, M., Harrison, M., and Geahlen, R. (1990) Anal. Biochem. 190, 60-65 |
| 38. | Pedersen, P. L., and Carafoli, E. (1987) Trends Biochem. Sci. 12, 146-150 |
| 39. | Vale, R. D. (1996) J. Cell Biol. 135, 291-305 |
| 40. | Welsh, M. J., Robertson, A. D., and Ostedgaard, L. S. (1998) Nature 396, 623-624 |
| 41. | Cross, S. J., Ciruela, A., Poomputsa, K., Romaniec, M., and Freedman, R. (1996) Biochem. J. 316, 615-622 |
| 42. | Morlang, S., Weglohner, W., and Franceschi, F. (1999) J. Mol. Biol. 294, 795-805 |
| 43. | Seckler, R., and Jaenicke, R. (1992) FASEB J. 6, 2545-2552 |
| 44. | Oberg, K., Chrunyk, B. A., Wetzel, R., and Fink, A. L. (1994) Biochemistry 33, 2628-2634 |
| 45. | Kennedy, K., and Traxler, B. (1999) J. Biol. Chem. 274, 6259-6264 |
| 46. | Wakagi, T., and Oshima, T. (1985) Biochim. Biophys. Acta 817, 33-41 |
| 47. | Jakob, U., Lilie, H., Meyer, I., and Buchner, J. (1995) J. Biol. Chem. 270, 7288-7294 |
| 48. | Jakob, U., Muse, W., Eser, M., and Bardwell, J. C. A. (1999) Cell 96, 341-352 |
| 49. | Hanley, P., Badger, J., Buldak, G., Reich, C., Woese, C., and Olsen, G. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 3578-3583 |
| 50. | Chakrabarty, S., and Varadarajan, R. (2000) FEBS Lett. 470, 65-69 |
This article has been cited by other articles:
![]() |
M. Thakur and P. K. Chakraborti GTPase Activity of Mycobacterial FtsZ Is Impaired Due to Its Transphosphorylation by the Eukaryotic-type Ser/Thr Kinase, PknA J. Biol. Chem., December 29, 2006; 281(52): 40107 - 40113. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. M. Xu, S. Adams, N.-H. Chua, and S. G. Moller AtNAP1 Represents an Atypical SufB Protein in Arabidopsis Plastids J. Biol. Chem., February 25, 2005; 280(8): 6648 - 6654. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tiwari, K. V. R. Kishan, T. Chakrabarti, and P. K. Chakraborti Amino Acid Residues Involved in Autophosphorylation and Phosphotransfer Activities Are Distinct in Nucleoside Diphosphate Kinase from Mycobacterium tuberculosis J. Biol. Chem., October 15, 2004; 279(42): 43595 - 43603. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Collins, R. P. Kawakami, B. M. Buddle, B. J. Wards, and G. W. de Lisle Different susceptibility of two animal species infected with isogenic mutants of Mycobacterium bovis identifies phoT as having roles in tuberculosis virulence and phosphate transport Microbiology, November 1, 2003; 149(11): 3203 - 3212. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sarin, G. P.S. Raghava, and P. K. Chakraborti Intrinsic contributions of polar amino acid residues toward thermal stability of an ABC-ATPase of mesophilic origin Protein Sci., September 1, 2003; 12(9): 2118 - 2120. [Abstract] [Full Text] [PDF] |
||||
| ||||||